Riskpilot← Back to searchSign inGet full accessTissue-Link ApS
APSActiveCVR 40633979Tagensvej 22Research and experimental development on natural sciences and engineering · NACE 7210Est. 2019— employees
Revenue 2025
DKK -818K
+105% vs 2024
EBITDA margin
109.2%
-124% vs 2024
Equity ratio
-24.1%
Financial strength
Net profit 2025
DKK -772K
-142% vs 2024
| Revenue | DKK -818K | +105% |
| EBITDA | DKK -893K | -124% |
| Net profit | DKK -772K | -142% |
| Total assets | DKK 3,5M | +153% |
| Equity | DKK -853K | -942% |
| Employees | — | — |
Legal name
Tissue-Link ApS
CVR number
40633979
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. juni 2019
Share capital
DKK 312.500
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden for bestyrelsen i forening med et bestyrelsesmedlem, formanden for bestyrelsen i forening med en direktør, eller en direktør i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er udvikling og salg af medicinsk udstyr og anden dermed beslægtet erhvervsaktivitet.
Address
Tagensvej 22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -34 | -214 | 367 | -231 | 17 | -399 | -818 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -75 |
| EBITDA | -34 | -214 | 367 | -231 | 17 | -399 | -893 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -34 | -214 | 367 | -231 | 17 | -399 | -893 |
| Net financials | -0 | -2 | -1 | -4 | -11 | -10 | -95 |
| Profit before tax | -34 | -216 | 366 | -235 | 6 | -408 | -989 |
| Tax | -0 | -26 | 39 | -51 | -0 | -89 | -217 |
| Net profit | -34 | -189 | 326 | -184 | 6 | -319 | -772 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 306 | 104 | 490 | 247 | 254 | 1.397 | 3.540 |
| Equity | 278 | 89 | 415 | 231 | 237 | -82 | -853 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 500 | 3.805 |
| Short-term debt | 28 | 15 | 75 | 16 | 17 | 979 | 588 |
| Total debt | 28 | 15 | 75 | 16 | 17 | 1.479 | 4.393 |
EBITDA margin
-89342600.0%
This company
15.8%
Market median
-565459594% vs market
20192025
Equity ratio
-24.1%
This company
38.2%
Market median
-163% vs market
20192025
Return on equity
-77152200.0%
This company
18.4%
Market median
-419305535% vs market
20192025
Net profit margin
-77152200.0%
This company
8.1%
Market median
-952496396% vs market
20192025
Asset turnover
-0.23×
This company
1.12×
Market median
-121% vs market
20192025
Debt / equity
5.15×
This company
0.62×
Market median
-731% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-06-24 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PA Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2019 | |
C- ApS | Company | 20.0% | 20.0% | 2019 |
LGM WINTHER HOLDING ApS | Company | 20.0% | 20.0% | 2019 |
| Individual | 20.0% | 20.0% | 2019 | |
AADALBIOTECH ApS | Company | 20.0% | 20.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tissue-Link ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Aadal Nielsen | Management | 0 companies |
| Charlotte Videbæk | Chairman | 0 companies |
| Niels Ole Mikkelsen | Board of Directors | 0 companies |
| Pär Ingemar Johansson | Board of Directors | 0 companies |
| Lars Ploug Hansen | Board of Directors | 0 companies |